Skip to main navigation Skip to search Skip to main content

KEYNOTE-B10" MK-3475-B10-0268: A Phase 4, single-arm, open-label clinical study of pembrolizumab (MK-3475) to evaluate the efficacy and safety of MK-3475 plus carboplatin and paclitaxel as firstline treatment of recurrent/metastatic head an

Project: Research

Project Details

StatusActive
Effective start/end date09/7/21 → 07/25/26

Funding

  • Merck Sharp and Dohme Limited Liability Corporation: $320,155.77